These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2081490)

  • 1. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
    Bannwarth B
    Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of ulcer and its prophylaxis in therapy with non-steroidal antirheumatic drugs].
    Köhler L; Mau W; Zeidler H
    Med Klin (Munich); 1997 Dec; 92(12):726-35. PubMed ID: 9483916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.
    Jouzeau JY; Terlain B; Abid A; Nédélec E; Netter P
    Drugs; 1997 Apr; 53(4):563-82. PubMed ID: 9098660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.
    Reuter BK; Asfaha S; Buret A; Sharkey KA; Wallace JL
    J Clin Invest; 1996 Nov; 98(9):2076-85. PubMed ID: 8903327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper gastrointestinal safety with nabumetone.
    Roth SH
    J Rheumatol Suppl; 1992 Nov; 36():74-9. PubMed ID: 1474539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the long-term safety experience of nabumetone.
    Willkens RF
    Drugs; 1990; 40 Suppl 5():34-7. PubMed ID: 2081490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety.
    Scott DL; Palmer RH
    Aliment Pharmacol Ther; 2000 Apr; 14(4):443-52. PubMed ID: 10759624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis.
    Mullen BJ
    Am J Med; 1987 Oct; 83(4B):74-7. PubMed ID: 3318433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile.
    Morgan GJ; Kaine J; DeLapp R; Palmer R
    J Clin Gastroenterol; 2001 Apr; 32(4):310-4. PubMed ID: 11276273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nabumetone versus naproxen in the treatment of osteoarthritis. A six-month trial.
    Poiley JE
    Am J Med; 1987 Oct; 83(4B):82-5. PubMed ID: 3318435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal syndromes associated with nonsteroidal antiinflammatory drugs.
    Clive DM; Stoff JS
    N Engl J Med; 1984 Mar; 310(9):563-72. PubMed ID: 6363936
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.